United States · Law · S
S. 1674 (111th)
Improving Access to Clinical Trials Act of 2009
Introduced
15 September 2009
Last action
5 October 2010 · President
Status
Became Public Law No: 111-255.
Sponsors
Ron Wyden, Rep. Dodd, Christopher J. [D-CT-2], Sen. Shelby, Richard C. [D-AL], Rep. Inhofe, James M. [R-OK-1], Richard Durbin, Sen. Brown, Sherrod [D-OH], Sen. Coburn, Tom [R-OK], Sen. Lincoln, Blanche L. [D-AR], Lisa Murkowski, Rep. Johnson, Tim [D-SD-At Large], Sen. Kerry, John F. [D-MA], Rep. Roberts, Pat [R-KS-1], Jeff Merkley, Sen. Brownback, Sam [R-KS], Sen. Menendez, Robert [D-NJ], Amy Klobuchar, Sen. Lautenberg, Frank R. [D-NJ], Sen. Franken, Al [D-MN], Sen. Burr, Richard [R-NC], Rep. Boxer, Barbara [D-CA-6], Sen. Burris, Roland [D-IL], Sen. Feinstein, Dianne [D-CA]
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Improving Access to Clinical Trials Act of 2009 - Amends title XVI (Supplemental Security Income) (SSI) of the Social Security Act (SSA) to exclude from income for SSI eligibility purposes any compensation in the amount of the first $2,000 per year received by an individual for participation in clinical trials involving research and testing of treatments for rare diseases or conditions. Amends SSA title XIX (Medicaid) to make a similar exclusion from income of such compensation for the purposes of eligibility under the Medicaid program. Directs the Comptroller General to study and report to Congress on the impact of this Act on enrollment of individuals who receive SSI benefits in clinical trials for rare diseases or conditions.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 September 2009
Introduced
Read twice and referred to the Committee on Finance.
Source: IntroReferral
15 September 2009
Introduced
Sponsor introductory remarks on measure. (CR S9379)
Source: IntroReferral
15 September 2009
Introduced
Introduced in Senate
Source: IntroReferral
5 August 2010
Passed
Passed Senate without amendment by Unanimous Consent. (text: CR S6979-6980)
Source: Floor
5 August 2010
Passed
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(text: CR S6979-6980)
Source: Floor
5 August 2010
Discharge
Senate Committee on Finance discharged by Unanimous Consent. (consideration: CR S6979-6980)
Source: Discharge
5 August 2010
Committee
Senate Committee on Finance discharged by Unanimous Consent.(consideration: CR S6979-6980)
Source: Committee
6 August 2010
Floor
Message on Senate action sent to the House.
Source: Floor
9 August 2010
Floor
Held at the desk.
Source: Floor
9 August 2010
Floor
Received in the House.
Source: Floor
23 September 2010
Action
Cleared for White House.
23 September 2010
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
23 September 2010
Passed
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6892)
Source: Floor
23 September 2010
Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H6892)
Source: Floor
23 September 2010
Floor
DEBATE - The House proceeded with forty minutes of debate on S. 1674.
Source: Floor
23 September 2010
Floor
Considered under suspension of the rules. (consideration: CR H6891-6896)
Source: Floor
23 September 2010
Floor
Mr. McDermott moved to suspend the rules and pass the bill.
Source: Floor
24 September 2010
Floor
Presented to President.
Source: Floor
24 September 2010
President
Presented to President.
Source: President
5 October 2010
Became law
Became Public Law No: 111-255.
Source: President
5 October 2010
Became law
Signed by President.
Source: BecameLaw
5 October 2010
President
Signed by President.
Source: President
Votes
No vote records are attached yet.
Versions
- Enrolled Bill · undated · Official file
- Public Law · 5 October 2010 · Official file
- Engrossed in Senate · 5 August 2010 · Official file
- Introduced in Senate · 15 September 2009 · Official file
Documents
12 official files
Enrolled Bill (text)
Enrolled Bill · EN
Enrolled Bill (PDF)
Enrolled Bill · EN
Public Law (text)
Public Law · EN · 5 October 2010
Public Law (PDF)
Public Law · EN · 5 October 2010
Public Law
summary · EN · 5 October 2010
Passed House without amendment
summary · EN · 23 September 2010
Engrossed in Senate (text)
Engrossed in Senate · EN · 5 August 2010
Engrossed in Senate (PDF)
Engrossed in Senate · EN · 5 August 2010
Passed Senate without amendment
summary · EN · 5 August 2010
Introduced in Senate (text)
Introduced in Senate · EN · 15 September 2009
Introduced in Senate (PDF)
Introduced in Senate · EN · 15 September 2009
Introduced in Senate
summary · EN · 15 September 2009
Sponsors
- Ron Wyden · D · Sponsor
- Rep. Dodd, Christopher J. [D-CT-2] · D · Sponsor
- Sen. Shelby, Richard C. [D-AL] · R · Sponsor
- Rep. Inhofe, James M. [R-OK-1] · R · Sponsor
- Richard Durbin · D · Cosponsor
- Sen. Brown, Sherrod [D-OH] · D · Cosponsor
- Sen. Coburn, Tom [R-OK] · R · Cosponsor
- Sen. Lincoln, Blanche L. [D-AR] · D · Cosponsor
- Lisa Murkowski · R · Cosponsor
- Rep. Johnson, Tim [D-SD-At Large] · D · Cosponsor
- Sen. Kerry, John F. [D-MA] · D · Cosponsor
- Rep. Roberts, Pat [R-KS-1] · R · Cosponsor
- Jeff Merkley · D · Cosponsor
- Sen. Brownback, Sam [R-KS] · R · Cosponsor
- Sen. Menendez, Robert [D-NJ] · D · Cosponsor
- Amy Klobuchar · D · Cosponsor
- Sen. Lautenberg, Frank R. [D-NJ] · D · Cosponsor
- Sen. Franken, Al [D-MN] · D · Cosponsor
- Sen. Burr, Richard [R-NC] · R · Cosponsor
- Rep. Boxer, Barbara [D-CA-6] · D · Cosponsor
- Sen. Burris, Roland [D-IL] · D · Cosponsor
- Sen. Feinstein, Dianne [D-CA] · D · Cosponsor
- · ssfi00 · Standing
Related records
- related to → Improving Access to Clinical Trials Act of 2009
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/111th-congress/senate-bill/1674
- Open data entity: https://api.congress.gov/v3/bill/111/s/1674
- us · 111-s-1674 · source updated 7 April 2025